Metsera Inc. share price logo

Metsera Inc. Share Price

NASDAQ: MTSR

Small Cap

$34.21

-1.46

(-4.09%)

as on

Metsera Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $33.88
    $36.61
    downward going graph

    0.96%

    Downside

    7.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.3
    $47.4
    downward going graph

    64.05%

    Downside

    38.56%

    Upside

    downward going graph

Metsera Inc. share price movements today

Previous Close
$35.67
Open
$36.17
Volume
1.0M
Day's Low - High
$33.88 - $36.61
52 Week Low - High
$12.3 - $47.4

Metsera Inc. Historical Returns

1 Month Return
+ 17.21 %
3 Month Return
+ 24.23 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Metsera Inc. Stock Fundamentals & Key Indicators

Check Metsera Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1B

EPS (TTM)

-3.23

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

15368600.00%

Metsera Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metsera Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Metsera Inc. image
Metsera Inc.
NA$4.1BNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B256.98%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.1B47.85%28.0731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B-3.43%14.1131.37%

Metsera Inc. Stock's Interest Amongst Investors

Search interest for Metsera Inc. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Metsera Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
0
-
Operating Income
-12
-21
-28
-111
-64
-79
-71
EBITDA
-10
-20
-26
-38
-132
-76
-68
Interest Expense
-
-
0
-
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-20
-26
-110
-61
-76
-68
Income Tax Expense
-
0
0
0
-8
-
-
Net Income
-11
-19
-26
-109
-52
-76
-68
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Metsera Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
0
Operating Income
-43
-224
EBITDA
-47
-218
Interest Expense
-
0
Depreciation
0
0
Income Before Tax
-47
-218
Income Tax Expense
-
-9
Net Income
-47
-209
Net Profit Margin
0.00%
0.00%

Metsera Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-19
-26
-109
-52
-76
-68
Operating Cash Flow
-15
-19
-28
-36
-54
-58
Investing Cash Flow
-
0
-
0
0
0
Financing Cash Flow
42
-6
139
202
288
-1
Change in Cash
27
-25
111
164
235
-57

Metsera Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
-47
-209
Operating Cash Flow
-35
-100
Investing Cash Flow
-28
0
Financing Cash Flow
123
378
Change in Cash
60
277

Insights on Metsera Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MTSR stock has moved up by 14.5%

About Metsera Inc.

Metsera, Inc. is a clinical-stage biotechnology company developing injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight and related conditions. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization, or HALO, half-life extending platform and its MOMENTUM oral NuSH analog peptide delivery platform to deliver highly differentiated product candidates. Its product pipeline includes MET-097i, MET-233i / MET-233i + MET-097i and MET-224o. MET-097i, its advanced product candidate, is a fully biased, monthly, subcutaneously injectable ultra-long acting GLP-1 RA. MET-233i is a subcutaneously injectable ultra-long-acting amylin analog, with enhanced solubility and miscibility with its other NuSH analog peptides. MET-224o is an oral, fully biased ultra-long acting GLP-1 RA. The Company's pipeline also includes MET-002o, MET-AMYo, MET-034i, MET-067i and MET-PYYi.
OrganisationMetsera Inc.
Headquarters3 World Trade Center, New York, NY, United States, 10007
CEOMr. Christopher Whitten Bernard
E-voting on sharesClick here to vote

Key Management of Metsera Inc.

Name

Title

Mr. Christopher Whitten Bernard

Co-Founder, President, CEO & Director

Mr. Paul L. Berns

Co-Founder & Lead Independent Director

Dr. Brian Hubbard Ph.D.

Chief Scientific Officer

Dr. Gbolahan Amusa Benz C.F.A., M.D.

EVP of Strategic Finance & Investor Relations

Mr. Daniel Hoey

Chief Technical Operations Officer

Mr. Matthew Lang J.D.

Chief Legal Officer & Secretary

Ms. Nancye Green

Chief Experience Officer

Dr. Clive A. Meanwell M.D., Ph.D.

Co-Founder & Executive Chairman

Mr. Christopher J. Visioli

Co-Founder, CFO & Chief Business Officer

Mr. Michael Donovan

Chief Design Officer

FAQs

What is Metsera Inc. share price today?

Metsera Inc. share price today is $34.21 as on at the close of the market. Metsera Inc. share today touched a day high of $36.61 and a low of $33.88.

What is the 52 week high and 52 week low for Metsera Inc. share?

Metsera Inc. share touched a 52 week high of $47.4 on and a 52 week low of $12.3 on . Metsera Inc. stock price today i.e. is closed at $34.21,which is 27.83% down from its 52 week high and 178.13% up from its 52 week low.

What is Metsera Inc.'s market capitalisation today?

Metsera Inc. market capitalisation is $0.00T as on .

How to invest in Metsera Inc. Stock (MTSR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Metsera Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metsera Inc. Shares that will get you 0.0438 shares as per Metsera Inc. share price of $34.21 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Metsera Inc. Stock (MTSR) from India?

Indian investors can start investing in Metsera Inc. (MTSR) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Metsera Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Metsera Inc. share’s latest price of $34.21 as on September 16, 2025 at 1:29 am IST, you will get 0.2923 shares of Metsera Inc.. Learn more about fractional shares .